Literature DB >> 22460948

The renal v-ATPase a4 subunit is expressed in specific subtypes of human gliomas.

Vincent Gleize1, Blandine Boisselier, Yannick Marie, Sandrine Poëa-Guyon, Marc Sanson, Nicolas Morel.   

Abstract

Vacuolar H(+) -ATPases (v-ATPases) are multimeric proton pumps which acidify various intra-cellular organelles and may participate in pHe and pHi regulation in cancer cell lines. The ATP6V0A4 gene encodes the a4 subunit which is expressed in kidney and epididymis. Because we found a4 mRNA highly expressed in C6Bu1 glioma cell line, we measured it in 205 glioma biopsies and 11 brain biopsies from epileptic patients. a4 was absent in epileptic brain biopsies, but was expressed by 34% (11/32) of grade III oligodendrogliomas, independently of the chromosome 1p19q codeletion. a4 expression in grade III oligodendrogliomas and oligoastrocytomas without the 1p19q codeletion tended to be associated with a shorter overall survival of patients. We also observed a4 expression in biopsies of pilocytic astrocytomas (68%; 19/28) and gangliogliomas (37%; 6/16). In pilocytic astrocytomas a4 expression was associated with a tandem duplication of the 7q34 chromosome region, distant 0.5 Mb to the ATP6V0A4 gene locus. In conclusion, a4 expression identifies subtypes of oligodendrogliomas, pilocytic astrocytomas and gangliogliomas and may contribute to refine characterization of these tumors. © 2012 Wiley Periodicals, Inc.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22460948     DOI: 10.1002/glia.22332

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  13 in total

Review 1.  Regulation of luminal acidification by the V-ATPase.

Authors:  Sylvie Breton; Dennis Brown
Journal:  Physiology (Bethesda)       Date:  2013-09

2.  Isoform-specific gene disruptions reveal a role for the V-ATPase subunit a4 isoform in the invasiveness of 4T1-12B breast cancer cells.

Authors:  Christina M McGuire; Michael P Collins; GeHong Sun-Wada; Yoh Wada; Michael Forgac
Journal:  J Biol Chem       Date:  2019-06-05       Impact factor: 5.157

Review 3.  Recent Insights into the Structure, Regulation, and Function of the V-ATPases.

Authors:  Kristina Cotter; Laura Stransky; Christina McGuire; Michael Forgac
Journal:  Trends Biochem Sci       Date:  2015-10       Impact factor: 13.807

Review 4.  The Function of V-ATPases in Cancer.

Authors:  Laura Stransky; Kristina Cotter; Michael Forgac
Journal:  Physiol Rev       Date:  2016-07       Impact factor: 37.312

5.  The vacuolar H+ ATPase is a novel therapeutic target for glioblastoma.

Authors:  Andrea Di Cristofori; Stefano Ferrero; Irene Bertolini; Gabriella Gaudioso; Maria Veronica Russo; Valeria Berno; Marco Vanini; Marco Locatelli; Mario Zavanone; Paolo Rampini; Thomas Vaccari; Manuela Caroli; Valentina Vaira
Journal:  Oncotarget       Date:  2015-07-10

6.  Extracellular and Luminal pH Regulation by Vacuolar H+-ATPase Isoform Expression and Targeting to the Plasma Membrane and Endosomes.

Authors:  Gina A Smith; Gareth J Howell; Clair Phillips; Stephen P Muench; Sreenivasan Ponnambalam; Michael A Harrison
Journal:  J Biol Chem       Date:  2016-02-24       Impact factor: 5.157

7.  The a3 isoform of subunit a of the vacuolar ATPase localizes to the plasma membrane of invasive breast tumor cells and is overexpressed in human breast cancer.

Authors:  Kristina Cotter; Rachel Liberman; GeHong Sun-Wada; Yoh Wada; Dennis Sgroi; Stephen Naber; Dennis Brown; Sylvie Breton; Michael Forgac
Journal:  Oncotarget       Date:  2016-07-19

Review 8.  Vacuolar ATPase as a potential therapeutic target and mediator of treatment resistance in cancer.

Authors:  Bradleigh Whitton; Haruko Okamoto; Graham Packham; Simon J Crabb
Journal:  Cancer Med       Date:  2018-06-21       Impact factor: 4.452

Review 9.  Involvement of tumor acidification in brain cancer pathophysiology.

Authors:  Avinash Honasoge; Harald Sontheimer
Journal:  Front Physiol       Date:  2013-11-01       Impact factor: 4.566

10.  Distinct esophageal adenocarcinoma molecular subtype has subtype-specific gene expression and mutation patterns.

Authors:  Xiangqian Guo; Yitai Tang; Wan Zhu
Journal:  BMC Genomics       Date:  2018-10-24       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.